Trial intelligence / Profile preview

Paliperidone ER vs Aripiprazole in Adolescent Schizophrenia

NCT01009047Phase 3Completed

Sponsor
Janssen Pharmaceutical
Start
Dec 2009
Primary completion
Jun 2012
Modality
Small Molecules
Countries
7
01

Overview

A Phase 3 trial of paliperidone in schizophrenia, sponsored by Janssen Pharmaceutical. Started Dec 2009; status: completed.

02

Drugs

paliperidone
03

Conditions

schizophrenia

Beyond the preview

Go deeper on NCT01009047.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01009047.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call